Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Anti-phosphatidylserine IgM and IgG antibodies are higher in vivax than falciparum malaria, and associated with early anemia in both species.

Barber BE, Grigg MJ, Piera K, Amante FH, William T, Boyle MJ, Minigo G, Dondorp AM, McCarthy JS, Anstey NM.

J Infect Dis. 2019 Jun 28. pii: jiz334. doi: 10.1093/infdis/jiz334. [Epub ahead of print]

PMID:
31250022
2.

The public health control of scabies: priorities for research and action.

Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, Enbiale W, Engels D, Hay RJ, Hendrickx D, Hotez PJ, Kaldor JM, Kama M, Mackenzie CD, McCarthy JS, Martin DL, Mengistu B, Maurer T, Negussu N, Romani L, Sokana O, Whitfeld MJ, Fuller LC, Steer AC.

Lancet. 2019 Jul 6;394(10192):81-92. doi: 10.1016/S0140-6736(19)31136-5. Epub 2019 Jun 6. Review.

PMID:
31178154
3.

Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection study.

Osowicki J, Azzopardi KI, Baker C, Waddington CS, Pandey M, Schuster T, Grobler A, Cheng AC, Pollard AJ, McCarthy JS, Good MF, Walker MJ, Dale JB, Batzloff MR, Carapetis JR, Smeesters PR, Steer AC.

Vaccine. 2019 Jun 6;37(26):3485-3494. doi: 10.1016/j.vaccine.2019.03.059. Epub 2019 May 14.

PMID:
31101422
4.

Treatment of pigs with endectocides as a complementary tool for combating malaria transmission by Anopheles farauti (s.s.) in Papua New Guinea.

Pasay CJ, Yakob L, Meredith HR, Stewart R, Mills PC, Dekkers MH, Ong O, Llewellyn S, Hugo RLE, McCarthy JS, Devine GJ.

Parasit Vectors. 2019 Mar 19;12(1):124. doi: 10.1186/s13071-019-3392-0.

5.

DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with Plasmodium falciparum.

Collins KA, Rückle T, Elliott S, Marquart L, Ballard E, Chalon S, Griffin P, Möhrle JJ, McCarthy JS.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e01837-18. doi: 10.1128/AAC.01837-18. Print 2019 Apr.

6.

An experimental human blood stage model for studying Plasmodium malariae infection.

Woodford J, Collins KA, Odedra A, Wang C, Kyung JI, Domingo GJ, Watts R, Marquart L, Berriman M, Otto TD, McCarthy JS.

J Infect Dis. 2019 Mar 10. pii: jiz102. doi: 10.1093/infdis/jiz102. [Epub ahead of print]

PMID:
30852586
7.

Risk factors for infection with soil-transmitted helminths during an integrated community level water, sanitation, and hygiene and deworming intervention in Timor-Leste.

Vaz Nery S, Clarke NE, Richardson A, Traub R, McCarthy JS, Gray DJ, Vallely AJ, Williams GM, Andrews RM, Campbell SJ, Clements ACA.

Int J Parasitol. 2019 Apr;49(5):389-396. doi: 10.1016/j.ijpara.2018.12.006. Epub 2019 Feb 22.

PMID:
30802450
8.

Human challenge models: tools to accelerate the development of malaria vaccines.

Cooper MM, Loiseau C, McCarthy JS, Doolan DL.

Expert Rev Vaccines. 2019 Mar;18(3):241-251. doi: 10.1080/14760584.2019.1580577. Epub 2019 Feb 27. Review.

PMID:
30732492
9.

WASH for WORMS: A Cluster-Randomized Controlled Trial of the Impact of a Community Integrated Water, Sanitation, and Hygiene and Deworming Intervention on Soil-Transmitted Helminth Infections.

Vaz Nery S, Traub RJ, McCarthy JS, Clarke NE, Amaral S, Llewellyn S, Weking E, Richardson A, Campbell SJ, Gray DJ, Vallely AJ, Williams GM, Andrews RM, Clements ACA.

Am J Trop Med Hyg. 2019 Mar;100(3):750-761. doi: 10.4269/ajtmh.18-0705.

PMID:
30628573
10.

Simultaneous Quantification of Plasmodium Antigens and Host Factor C-Reactive Protein in Asymptomatic Individuals with Confirmed Malaria by Use of a Novel Multiplex Immunoassay.

Jang IK, Tyler A, Lyman C, Kahn M, Kalnoky M, Rek JC, Arinaitwe E, Adrama H, Murphy M, Imwong M, Ling CL, Proux S, Haohankhunnatham W, Rist M, Seilie AM, Hanron A, Daza G, Chang M, Das S, Barney R, Rashid A, Landier J, Boyle DS, Murphy SC, McCarthy JS, Nosten F, Greenhouse B, Domingo GJ.

J Clin Microbiol. 2019 Jan 2;57(1). pii: e00948-18. doi: 10.1128/JCM.00948-18. Print 2019 Jan.

11.
12.

Soil-Transmitted Helminths in Children in a Remote Aboriginal Community in the Northern Territory: Hookworm is Rare but Strongyloides stercoralis and Trichuris trichiura Persist.

Holt DC, Shield J, Harris TM, Mounsey KE, Aland K, McCarthy JS, Currie BJ, Kearns TM.

Trop Med Infect Dis. 2017 Oct 4;2(4). pii: E51. doi: 10.3390/tropicalmed2040051.

13.

Plasmodium falciparum Activates CD16+ Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent Malaria.

Loughland JR, Woodberry T, Boyle MJ, Tipping PE, Piera KA, Amante FH, Kenangalem E, Price RN, Engwerda CR, Anstey NM, McCarthy JS, Minigo G.

J Infect Dis. 2019 Jan 29;219(4):660-671. doi: 10.1093/infdis/jiy555.

14.

Diurnal variation in expired breath volatiles in malaria-infected and healthy volunteers.

Berna AZ, McCarthy JS, Wang XR, Michie M, Bravo FG, Cassells J, Trowell SC.

J Breath Res. 2018 Sep 19;12(4):046014. doi: 10.1088/1752-7163/aadbbb.

PMID:
30129561
15.

Within-host modeling of blood-stage malaria.

Khoury DS, Aogo R, Randriafanomezantsoa-Radohery G, McCaw JM, Simpson JA, McCarthy JS, Haque A, Cromer D, Davenport MP.

Immunol Rev. 2018 Sep;285(1):168-193. doi: 10.1111/imr.12697. Review.

PMID:
30129195
16.

Assessing Plasmodium falciparum transmission in mosquito-feeding assays using quantitative PCR.

Wang CYT, McCarthy JS, Stone WJ, Bousema T, Collins KA, Bialasiewicz S.

Malar J. 2018 Jul 5;17(1):249. doi: 10.1186/s12936-018-2382-6.

17.

Use of quantitative PCR to assess the efficacy of albendazole against Necator americanus and Ascaris spp. in Manufahi District, Timor-Leste.

Vaz Nery S, Qi J, Llewellyn S, Clarke NE, Traub R, Gray DJ, Vallely AJ, Williams GM, Andrews RM, McCarthy JS, Clements ACA.

Parasit Vectors. 2018 Jun 28;11(1):373. doi: 10.1186/s13071-018-2838-0.

18.

Early Changes in CD4+ T-Cell Activation During Blood-Stage Plasmodium falciparum Infection.

Edwards CL, Ng SS, Corvino D, Montes de Oca M, de Labastida Rivera F, Nones K, Lakis V, Waddell N, Amante FH, McCarthy JS, Engwerda CR.

J Infect Dis. 2018 Aug 24;218(7):1119-1129. doi: 10.1093/infdis/jiy281.

PMID:
29757416
19.

(S)WASH-D for Worms: A pilot study investigating the differential impact of school- versus community-based integrated control programs for soil-transmitted helminths.

Clarke NE, Clements ACA, Amaral S, Richardson A, McCarthy JS, McGown J, Bryan S, Gray DJ, Nery SV.

PLoS Negl Trop Dis. 2018 May 3;12(5):e0006389. doi: 10.1371/journal.pntd.0006389. eCollection 2018 May.

20.

Human Immunization With a Polymorphic Malaria Vaccine Candidate Induced Antibodies to Conserved Epitopes That Promote Functional Antibodies to Multiple Parasite Strains.

Feng G, Boyle MJ, Cross N, Chan JA, Reiling L, Osier F, Stanisic DI, Mueller I, Anders RF, McCarthy JS, Richards JS, Beeson JG.

J Infect Dis. 2018 Jun 5;218(1):35-43. doi: 10.1093/infdis/jiy170.

PMID:
29584918
21.

The Dynamics of Liver Function Test Abnormalities after Malaria Infection: A Retrospective Observational Study.

Woodford J, Shanks GD, Griffin P, Chalon S, McCarthy JS.

Am J Trop Med Hyg. 2018 Apr;98(4):1113-1119. doi: 10.4269/ajtmh.17-0754. Epub 2018 Feb 8.

22.

A controlled human malaria infection model enabling evaluation of transmission-blocking interventions.

Collins KA, Wang CY, Adams M, Mitchell H, Rampton M, Elliott S, Reuling IJ, Bousema T, Sauerwein R, Chalon S, Möhrle JJ, McCarthy JS.

J Clin Invest. 2018 Apr 2;128(4):1551-1562. doi: 10.1172/JCI98012. Epub 2018 Mar 12.

23.

Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.

Payne RO, Silk SE, Elias SC, Miura K, Diouf A, Galaway F, de Graaf H, Brendish NJ, Poulton ID, Griffiths OJ, Edwards NJ, Jin J, Labbé GM, Alanine DG, Siani L, Di Marco S, Roberts R, Green N, Berrie E, Ishizuka AS, Nielsen CM, Bardelli M, Partey FD, Ofori MF, Barfod L, Wambua J, Murungi LM, Osier FH, Biswas S, McCarthy JS, Minassian AM, Ashfield R, Viebig NK, Nugent FL, Douglas AD, Vekemans J, Wright GJ, Faust SN, Hill AV, Long CA, Lawrie AM, Draper SJ.

JCI Insight. 2017 Nov 2;2(21). pii: 96381. doi: 10.1172/jci.insight.96381.

24.

Controlled Human Malaria Infection: Applications, Advances, and Challenges.

Stanisic DI, McCarthy JS, Good MF.

Infect Immun. 2017 Dec 19;86(1). pii: e00479-17. doi: 10.1128/IAI.00479-17. Print 2018 Jan. Review.

25.

Comparison of statistical models to estimate parasite growth rate in the induced blood stage malaria model.

Wockner LF, Hoffmann I, O'Rourke P, McCarthy JS, Marquart L.

Malar J. 2017 Aug 25;16(1):352. doi: 10.1186/s12936-017-1999-1.

26.

Performance of a High-Sensitivity Rapid Diagnostic Test for Plasmodium falciparum Malaria in Asymptomatic Individuals from Uganda and Myanmar and Naive Human Challenge Infections.

Das S, Jang IK, Barney B, Peck R, Rek JC, Arinaitwe E, Adrama H, Murphy M, Imwong M, Ling CL, Proux S, Haohankhunnatham W, Rist M, Seilie AM, Hanron A, Daza G, Chang M, Nakamura T, Kalnoky M, Labarre P, Murphy SC, McCarthy JS, Nosten F, Greenhouse B, Allauzen S, Domingo GJ.

Am J Trop Med Hyg. 2017 Nov;97(5):1540-1550. doi: 10.4269/ajtmh.17-0245. Epub 2017 Aug 18.

27.

Dichotomous miR expression and immune responses following primary blood-stage malaria.

Burel JG, Apte SH, Groves PL, Boyle MJ, Langer C, Beeson JG, McCarthy JS, Doolan DL.

JCI Insight. 2017 Aug 3;2(15). pii: 93434. doi: 10.1172/jci.insight.93434. eCollection 2017 Aug 3.

28.

A novel, species-specific, real-time PCR assay for the detection of the emerging zoonotic parasite Ancylostoma ceylanicum in human stool.

Papaiakovou M, Pilotte N, Grant JR, Traub RJ, Llewellyn S, McCarthy JS, Krolewiecki AJ, Cimino R, Mejia R, Williams SA.

PLoS Negl Trop Dis. 2017 Jul 10;11(7):e0005734. doi: 10.1371/journal.pntd.0005734. eCollection 2017 Jul.

29.

Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies.

Payne RO, Silk SE, Elias SC, Milne KH, Rawlinson TA, Llewellyn D, Shakri AR, Jin J, Labbé GM, Edwards NJ, Poulton ID, Roberts R, Farid R, Jørgensen T, Alanine DG, de Cassan SC, Higgins MK, Otto TD, McCarthy JS, de Jongh WA, Nicosia A, Moyle S, Hill AV, Berrie E, Chitnis CE, Lawrie AM, Draper SJ.

JCI Insight. 2017 Jun 15;2(12). pii: 93683. doi: 10.1172/jci.insight.93683. eCollection 2017 Jun 15.

30.

Plasmacytoid dendritic cells appear inactive during sub-microscopic Plasmodium falciparum blood-stage infection, yet retain their ability to respond to TLR stimulation.

Loughland JR, Minigo G, Sarovich DS, Field M, Tipping PE, Montes de Oca M, Piera KA, Amante FH, Barber BE, Grigg MJ, William T, Good MF, Doolan DL, Engwerda CR, Anstey NM, McCarthy JS, Woodberry T.

Sci Rep. 2017 Jun 1;7(1):2596. doi: 10.1038/s41598-017-02096-2.

31.

In Vitro Efficacy of Moxidectin versus Ivermectin against Sarcoptes scabiei.

Mounsey KE, Walton SF, Innes A, Cash-Deans S, McCarthy JS.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00381-17. doi: 10.1128/AAC.00381-17. Print 2017 Aug.

32.

Initiation of gametocytogenesis at very low parasite density in Plasmodium falciparum infection.

Farid R, Dixon MW, Tilley L, McCarthy JS.

J Infect Dis. 2017 Apr 1;215(7):1167-1174. doi: 10.1093/infdis/jix035.

33.

Investigations into the association between soil-transmitted helminth infections, haemoglobin and child development indices in Manufahi District, Timor-Leste.

Campbell SJ, Nery SV, D'Este CA, Gray DJ, McCarthy JS, Traub RJ, Andrews RM, Llewellyn S, Vallely AJ, Williams GM, Clements ACA.

Parasit Vectors. 2017 Apr 19;10(1):192. doi: 10.1186/s13071-017-2084-x.

34.

Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study.

McCarthy JS, Lotharius J, Rückle T, Chalon S, Phillips MA, Elliott S, Sekuloski S, Griffin P, Ng CL, Fidock DA, Marquart L, Williams NS, Gobeau N, Bebrevska L, Rosario M, Marsh K, Möhrle JJ.

Lancet Infect Dis. 2017 Jun;17(6):626-635. doi: 10.1016/S1473-3099(17)30171-8. Epub 2017 Mar 28.

35.

Water, Sanitation and Hygiene (WASH) and environmental risk factors for soil-transmitted helminth intensity of infection in Timor-Leste, using real time PCR.

Campbell SJ, Nery SV, Wardell R, D'Este CA, Gray DJ, McCarthy JS, Traub RJ, Andrews RM, Llewellyn S, Vallely AJ, Williams GM, Clements AC.

PLoS Negl Trop Dis. 2017 Mar 27;11(3):e0005393. doi: 10.1371/journal.pntd.0005393. eCollection 2017 Mar.

36.

Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c+ Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell Activation.

Woodberry T, Loughland JR, Minigo G, Burel JG, Amante FH, Piera KA, McNeil Y, Yeo TW, Good MF, Doolan DL, Engwerda CR, McCarthy JS, Anstey NM.

Infect Immun. 2017 May 23;85(6). pii: e00986-16. doi: 10.1128/IAI.00986-16. Print 2017 Jun.

37.

Polyfunctional and IFN-γ monofunctional human CD4+ T cell populations are molecularly distinct.

Burel JG, Apte SH, Groves PL, McCarthy JS, Doolan DL.

JCI Insight. 2017 Feb 9;2(3):e87499. doi: 10.1172/jci.insight.87499.

38.

Griseofulvin impairs intraerythrocytic growth of Plasmodium falciparum through ferrochelatase inhibition but lacks activity in an experimental human infection study.

Smith CM, Jerkovic A, Truong TT, Foote SJ, McCarthy JS, McMorran BJ.

Sci Rep. 2017 Feb 8;7:41975. doi: 10.1038/srep41975.

39.

Plasmodium malariae and P. ovale genomes provide insights into malaria parasite evolution.

Rutledge GG, Böhme U, Sanders M, Reid AJ, Cotton JA, Maiga-Ascofare O, Djimdé AA, Apinjoh TO, Amenga-Etego L, Manske M, Barnwell JW, Renaud F, Ollomo B, Prugnolle F, Anstey NM, Auburn S, Price RN, McCarthy JS, Kwiatkowski DP, Newbold CI, Berriman M, Otto TD.

Nature. 2017 Feb 2;542(7639):101-104. doi: 10.1038/nature21038. Epub 2017 Jan 25.

40.

Plasmodium vivax Controlled Human Malaria Infection - Progress and Prospects.

Payne RO, Griffin PM, McCarthy JS, Draper SJ.

Trends Parasitol. 2017 Feb;33(2):141-150. doi: 10.1016/j.pt.2016.11.001. Epub 2016 Dec 10. Review.

41.

Plasmodium vivax but Not Plasmodium falciparum Blood-Stage Infection in Humans Is Associated with the Expansion of a CD8+ T Cell Population with Cytotoxic Potential.

Burel JG, Apte SH, McCarthy JS, Doolan DL.

PLoS Negl Trop Dis. 2016 Dec 8;10(12):e0005031. doi: 10.1371/journal.pntd.0005031. eCollection 2016 Dec.

42.

Hookworm infection.

Loukas A, Hotez PJ, Diemert D, Yazdanbakhsh M, McCarthy JS, Correa-Oliveira R, Croese J, Bethony JM.

Nat Rev Dis Primers. 2016 Dec 8;2:16088. doi: 10.1038/nrdp.2016.88. Review.

PMID:
27929101
43.

The Impact of Established Immunoregulatory Networks on Vaccine Efficacy and the Development of Immunity to Malaria.

Montes de Oca M, Good MF, McCarthy JS, Engwerda CR.

J Immunol. 2016 Dec 15;197(12):4518-4526. Review.

44.

Opportunities for Integrated Control of Neglected Tropical Diseases That Affect the Skin.

Engelman D, Fuller LC, Solomon AW, McCarthy JS, Hay RJ, Lammie PJ, Steer AC.

Trends Parasitol. 2016 Nov;32(11):843-854. doi: 10.1016/j.pt.2016.08.005. Epub 2016 Sep 13. Review.

PMID:
27638231
45.

Water, sanitation and hygiene related risk factors for soil-transmitted helminth and Giardia duodenalis infections in rural communities in Timor-Leste.

Campbell SJ, Nery SV, D'Este CA, Gray DJ, McCarthy JS, Traub RJ, Andrews RM, Llewellyn S, Vallely AJ, Williams GM, Amaral S, Clements AC.

Int J Parasitol. 2016 Nov;46(12):771-779. doi: 10.1016/j.ijpara.2016.07.005. Epub 2016 Sep 8.

PMID:
27616734
46.

Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection.

Montes de Oca M, Kumar R, Rivera FL, Amante FH, Sheel M, Faleiro RJ, Bunn PT, Best SE, Beattie L, Ng SS, Edwards CL, Boyle GM, Price RN, Anstey NM, Loughland JR, Burel J, Doolan DL, Haque A, McCarthy JS, Engwerda CR.

Cell Rep. 2016 Oct 4;17(2):399-412. doi: 10.1016/j.celrep.2016.09.015.

47.

Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ Production.

Burel JG, Apte SH, Groves PL, Klein K, McCarthy JS, Doolan DL.

PLoS Pathog. 2016 Sep 23;12(9):e1005839. doi: 10.1371/journal.ppat.1005839. eCollection 2016 Sep.

48.

A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study.

McCarthy JS, Rückle T, Djeriou E, Cantalloube C, Ter-Minassian D, Baker M, O'Rourke P, Griffin P, Marquart L, Hooft van Huijsduijnen R, Möhrle JJ.

Malar J. 2016 Sep 13;15:469. doi: 10.1186/s12936-016-1511-3.

49.

Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity.

Karunarathne DS, Horne-Debets JM, Huang JX, Faleiro R, Leow CY, Amante F, Watkins TS, Miles JJ, Dwyer PJ, Stacey KJ, Yarski M, Poh CM, Lee JS, Cooper MA, Rénia L, Richard D, McCarthy JS, Sharpe AH, Wykes MN.

Immunity. 2016 Aug 16;45(2):333-45. doi: 10.1016/j.immuni.2016.07.017.

50.

Infectivity of Plasmodium falciparum in Malaria-Naive Individuals Is Related to Knob Expression and Cytoadherence of the Parasite.

Stanisic DI, Gerrard J, Fink J, Griffin PM, Liu XQ, Sundac L, Sekuloski S, Rodriguez IB, Pingnet J, Yang Y, Zhou Y, Trenholme KR, Wang CY, Hackett H, Chan JA, Langer C, Hanssen E, Hoffman SL, Beeson JG, McCarthy JS, Good MF.

Infect Immun. 2016 Aug 19;84(9):2689-96. doi: 10.1128/IAI.00414-16. Print 2016 Sep.

Supplemental Content

Loading ...
Support Center